Search results
North American Morning Briefing: Stock Futures Flat Ahead of Retail Earnings
Morningstar· 2 hours agoOPENING CALL Stock futures were little changed on Tuesday with consumer spending in focus, as a slew of earnings from retailers were due. Expected results from Lowe's, Macy's, AutoZone and Urban Outfitters may give investors some new hints about
5 things I look for in a good memory foam mattress — plus the 3 I'd buy in the Memorial Day sales
Tom's Guide via Yahoo News· 22 hours agoWhen looking for a memory foam mattress, look for how many nights the brand allows you to try it for...
Compugen stock target cut on colorectal cancer trial woes By Investing.com
Investing.com· 19 hours agoOn Monday, Truist Securities adjusted its outlook on Compugen shares (NASDAQ:CGEN), a biotechnology...
Cytisinicline shows promise in vaping cessation trial By Investing.com
Investing.com· 4 days ago(NASDAQ: NASDAQ:ACHV), a pharmaceutical company focused on the development of treatments for smoking...
'Dateline' Correspondent Andrea Canning Talks Her New Podcast, Work-Life Balance and Her Surprising...
First for Women via Yahoo News· 5 days agoAsked how she balances it all, Canning says, “Give a busy person the work and a busy person will get...
What is a SweetNight mattress and should you buy one in the Memorial Day sales?
Tom's Guide via Yahoo News· 20 hours agoIt currently has a 4.8 star rating (out of 415 reviews) and has three firmness options in one design...
Regenxbio shares target lifted by H.C. Wainwright, cites CAMPSIITE trial By Investing.com
Investing.com· 6 days agoOn Wednesday, H.C. Wainwright adjusted its outlook on Regenxbio Inc. (NASDAQ:RGNX) shares,...
MediPharm Labs Reports First Quarter Results
FOX 4 Kansas City· 6 days agoMediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in...
Guy Fieri shares how he lost over 30 pounds, inclduing weight vested training
ABC News· 15 hours agoGuy Fieri is crediting his weight loss to an intense workout routine inspired by military training...
Earnings call: Aptose Biosciences targets AML treatment with tuspetinib By Investing.com
Investing.com· 6 days agoAptose Biosciences (NASDAQ:APTO) has focused its efforts on developing tuspetinib as part of a novel...